10:20 AM EDT, 09/05/2025 (MT Newswires) -- Goldman Sachs Group ( GS ) is among the banks competing with private credit companies to fund potential buyers of Advent International's Zentiva, Bloomberg reported Friday, citing people familiar with the matter.

Lenders are readying up to 3 billion euros ($3.52 billion) of debt financing to support a potential sale of Zentiva as a deal approaches, the report said.

Among those interested in the generic drugmaker are TPG (TPG) and GTCR, according to the report.

Goldman, Advent, TPG and GTCR didn't immediately respond to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 740.48, Change: -8.42, Percent Change: -1.12